Laboratorio Farmaceutico Erfo S p A : ERFO - EGM investor day_2023.05.09

EGM INVESTOR DAY

Milano, 09.05.2023

Speaker

Alessandro Cutè

Chairman & CEO

In 2010 he started to design the Diètnatural model, until he founded Erfo s.r.l. in 2013. Before devoting himself to the creation of Diètnatural he accumulated managerial experience in the Public Administration and in sports clubs of the top football series, thus maturing the passion for well-being and healthy eating.

2

Agenda

1.

2.

3.

4.

At a Glance

Business Model & Go to market

Key Financials

Strategy & Investment Plan

3

At a Glance

Laboratorio Farmaceutico Erfo S.p.A. is a Benefit Corporation and Innovative SME with its headquarters in Villafranca Tirrena (ME). It is specialized in the formulation, production and marketing of nutraceutical products, originated from a continuous Research and Development activity which has already generated over 70 products.

Marketing and distribution takes place through three business lines:

1. Diètnatural: format conceived and developed by the company and dedicated to the sale of nutraceutical products combined with continuous assistance in the nutritional path of each client, through scalable and high-margincommercial formulas (i.e. direct and franchised single-brand centers)
2. BodySano: format developed in France and Belgium, dedicated to the sale of nutraceutical products, combined with a personalized nutritional path and innovative beauty treatments
3. Medical Division: new product line born in 2021 and dedicated to nutraceuticals for different specific therapeutic areas gastroenterology ,urology and, since 2022, gynecology, with important developments already planned in the orthopedic area.

36%	-1 Mln€ (Net Cash)
EBITDA Margin adj FY22	Adj. Net Fin. Position FY22

>70	145
# Developed products	# Total Active centers
(FY22)	(FY22)

NET INCOME '13-22 +16 %CAGR

REVENUE '13-22 +24%CAGR

6.038

	4.681		5.158	5.028
	4.200
4.106
1.169	1.310	1.140	1.117	716833
2018	2019	2020	2021**	2022

NET INCOME NET INCOME proforma* Revenue Revenue proforma*

The company's strategy is to invest in the development of both business lines, and in particular through:

• New openings of Diètnatural and Bodysano centers on the European territory through new franchise collaborations
• Development of the Medical Division line both in terms of product (i.e., R&D) and in terms of commercial network (i.e., increase in the number of single-agent Scientific Drug Informants)
• Investments in marketing, digitalization and improvement of the user experience related to the "Dietplan" app

*The 2022 proforma consolidated figures (unaudited) assume the full consolidation of Bodysano Gruop and Dietnatural Nutricenter S.l

4

**The 2021 comparative consolidated figures (unaudited) were constructed assuming the full consolidation of Dietnatural Nutricenter S.l. and Giano Pharma s.r.l. (a wholly owned subsidiary in 2021, merged by incorporation on August 29, 2022. Refer to the press release of March 31st, 2022 for further information.

Storyline

2013

• Erfo S.r.l.

is founded

2017

• Formalization of R&D activities and realization of production lines (solid

2015 + liquid products) with Industry 4.0 standards

• Plant opening with over 1000mq area and production lines

2020

• Split of the non-productive real estate area in favor of the parent company AC Investment S.p.A.
• Opening of the pilot center in Spain Awarded as «Growth Leades» from Sole 24 Ore newspaper

2018

• Transformation in S.p.A.

2022

• IPO on Exuronext Growth Milan
• Transformation into a Benefit Corporation
• Acquisition of BodySano: French and Belgian group

2021

• Development of

"Medical Division"

2014

• Diètnatural awarded as «Best Franchise of the world»

2016

• ISO 9001:2015 and BIO

2019

Certification

• 100th Diètnatural center opening

• Awarded as «Growth

Leades» from Sole 24

Ore newspaper for the

second time

Centers	13	43	66	101	111	118
# of Diètnatural
# of BodySano						27
Centers
Year	2013	2015	2017	2019	2021	2022

5